{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:26:15Z","timestamp":1787840775452,"version":"build-2784847793"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 5","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>\n                      Oral submucous fibrosis (OSMF) is a chronic oral potentially malignant disorder affecting the oral mucosa. The habit of areca nut chewing is established to be the causative factor. Various treatment modalities are available for managing OSMF. Colchicine obtained from plants of the\n                      <jats:italic toggle=\"yes\">Colchicum<\/jats:italic>\n                      genus can downregulate collagen synthesis and upregulate collagenolytic activity, thereby establishing its antifibrotic property. Hence, the objective of the current study is to assess the efficacy of colchicine in the treatment of OSMF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive search was conducted in MEDLINE via PubMed, Cochrane, ProQuest, Ovid, and Google Scholar, and the clinical trials evaluating the efficacy of oral colchicine for the treatment of OSMF were included. The Cochrane risk of bias tool and GRADE were utilized for assessing the quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Three clinical trials (one randomized and two non-randomized trials) comprising 110 OSMF patients followed the eligibility criteria. The follow-up time for the patients was between 3 and 6 months. Mouth opening and burning sensation were the primary outcomes of interest. The risk of bias was found to be high in the studies included. GRADE quality assessment showed moderate quality for one study and two studies to be of low-quality evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This review suggests that oral colchicine is efficacious in the management of OSMF and more distinctly in improving mouth opening. Considering the significant side effects from conventional treatment for OSMF, colchicine can be an effective modality in improving burning sensation and mouth opening in patients with OSMF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_1313_24","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:03:04Z","timestamp":1738234984000},"page":"S4289-S4298","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Colchicine in the Management of Oral Submucous Fibrosis \u2013 A Systematic Review and GRADE Assessment"],"prefix":"10.4103","volume":"16","author":[{"given":"Naveenaa","family":"Chellapandian","sequence":"first","affiliation":[{"name":"Department of Oral Medicine and Radiology, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth (Deemed to be University) Pondicherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Sekizhar","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine and Radiology, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth (Deemed to be University) Pondicherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavithranand","family":"Ammayappan","sequence":"additional","affiliation":[{"name":"Department of Orthodontics and Dentofacial Orthopedics, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth (Deemed to be University), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar Chandan","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ismail Abdelrahman","family":"Nagy","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivashankar","family":"Kengadaran","sequence":"additional","affiliation":[{"name":"Public Health Dentistry, Indira Gandhi Institute of Dental Sciences, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artak","family":"Heboyan","sequence":"additional","affiliation":[{"name":"Department of Prosthodontics, Faculty of Stomatology, Yerevan State Medical University after Mkhitar Heratsi, Str. Koryun 2, Yerevan 0025, Armenia"},{"name":"Department of Prosthodontics, School of Dentistry, Tehran University of Medical Sciences, North Karegar St, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Shrivastava","sequence":"additional","affiliation":[{"name":"Department of Preventive Dentistry, College of Dentistry, Jouf University, Sakaka, Saudi Arabia"},{"name":"Department of Periodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SiMatS), Saveetha University, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"Suppl 2","key":"R1-20250130","doi-asserted-by":"crossref","first-page":"S1461","DOI":"10.4103\/jpbs.jpbs_966_23","article-title":"Awareness of oral submucous fibrosis among the quid-chewing South-Asian expatriates in the United Arab Emirates","volume":"16","author":"Almuzaien","year":"2024","journal-title":"J Pharm Bioallied Sci"},{"key":"R2-20250130","doi-asserted-by":"crossref","DOI":"10.1186\/s40463-020-0399-7","article-title":"Oral submucous fibrosis:A contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management","volume":"49","author":"Rao","year":"2020","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R3-20250130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/0975-7406.191941","article-title":"Comparative evaluation of serum and salivary immunoglobulin G and A levels with total serum protein in oral submucous fibrosis patients:A case control study","volume":"8","author":"Kandasamy","year":"2016","journal-title":"J Pharm Bioallied Sci"},{"key":"R4-20250130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5455\/jihp.20140406010651","article-title":"Does clinical staging and histological grading show parallelism in oral submucous fibrosis?A retrospective study from an Indian City","volume":"2","author":"Narayan","year":"2014","journal-title":"J Interdiscip Histopathol"},{"key":"R5-20250130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jobcr.2019.06.016","article-title":"Proposed clinical definition for oral submucous fibrosis","volume":"9","author":"More","year":"2019","journal-title":"J Oral Biol Craniofac Res"},{"issue":"Suppl 2","key":"R6-20250130","doi-asserted-by":"crossref","first-page":"S1136","DOI":"10.4103\/jpbs.jpbs_1287_23","article-title":"Utilizing artificial intelligence application for diagnosis of oral lesions and assisting young oral histopathologist in deriving diagnosis from provided features \u2013A pilot study","volume":"16","author":"Islam","year":"2024","journal-title":"J Pharm Bioallied Sci"},{"key":"R7-20250130","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/ijms20122940","article-title":"Oral submucous fibrosis:A review on etiopathogenesis, diagnosis, and therapy","volume":"20","author":"Shih","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R8-20250130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jop.12582","article-title":"Oral submucous fibrosis:An update on pathophysiology of malignant transformation","volume":"46","author":"Arakeri","year":"2017","journal-title":"J Oral Pathol Med"},{"key":"R9-20250130","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/0022034519851804","article-title":"YAP-induced endothelial-mesenchymal transition in oral submucous fibrosis","volume":"98","author":"Li","year":"2019","journal-title":"J Dent Res"},{"key":"R10-20250130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jfma.2017.07.003","article-title":"Arecoline activates latent transforming growth factor B1 via mitochondrial reactive oxygen species in buccal fibroblasts:Suppression by epigallocatechin-3-gallate","volume":"117","author":"Hsieh","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"R11-20250130","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.4103\/jpbs.jpbs_408_21","article-title":"Phenotypic expression of oral fibroblasts derived from oral submucous fibrosis:An assay through cell culture","volume":"13","author":"Banerjee","year":"2021","journal-title":"J Pharm Bioallied Sci"},{"key":"R12-20250130","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/jcm11071793","article-title":"Malignant transformation rate of oral submucous fibrosis:A systematic review and meta-analysis","volume":"11","author":"Murthy","year":"2022","journal-title":"J Clin Med"},{"key":"R13-20250130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/ors.12771","article-title":"Malignant transformation rate of oral submucous fibrosis:A systematic review and meta-analysis","volume":"16","author":"Nayanar","year":"2023","journal-title":"Oral Surg"},{"key":"R14-20250130","first-page":"399","article-title":"An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis","volume":"13","author":"Bari","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"R15-20250130","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0714.2008.00643.x","article-title":"Fingerprinting genomic instability in oral submucous fibrosis","volume":"37","author":"Teh","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"R16-20250130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/prd.12277","article-title":"Oral submucous fibrosis:A global challenge. Rising incidence, risk factors, management, and research priorities","volume":"80","author":"Ray","year":"2019","journal-title":"Periodontol 2000"},{"key":"R17-20250130","article-title":"Comparative assessment of E-Cadherin's expression between the metastatic and non-metastatic oral squamous cell carcinoma:An immunohistochemical study","volume":"23","author":"Khan","year":"2023","journal-title":"Pesqui Bras Odontopediatria Clin Integr"},{"key":"R18-20250130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/0972-1363.195096","article-title":"Expression of cyclo-oxygenase-2 enzyme in the tissue samples of patients with various clinicopathological stages of oral leukoplakia and oral squamous cell carcinoma","volume":"28","author":"Aruldoss","year":"2016","journal-title":"J Indian Acad Oral Med Radiol"},{"key":"R19-20250130","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jobcr.2020.08.004","article-title":"Medicinal management of oral submucous fibrosis in the past decade- A systematic review","volume":"10","author":"More","year":"2020","journal-title":"J Oral Biol Craniofac Res"},{"key":"R20-20250130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine:An ancient drug with novel applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"Br J Dermatol"},{"key":"R21-20250130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"R22-20250130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.1967.03120080059008","article-title":"Diagnostic value of the colchicine therapeutic trial","volume":"199","author":"Wallace","year":"1967","journal-title":"JAMA J Am Med Assoc"},{"key":"R23-20250130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines:3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R24-20250130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3126\/jngmc.v14i2.21542","article-title":"Comparative study of intralesional dexamethasone plus hyaluronidase and oral colchicine in patients with oral submucous fibrosis","volume":"14","author":"Neupane","year":"2018","journal-title":"J Nepal Med Coll"},{"key":"R25-20250130","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.53730\/ijhs.v6nS1.8474","article-title":"To determine the efficacy of colchicine as a monotherapy in Oral Submucous Fibrosis (OSMF) patients","author":"Sidana","year":"2022","journal-title":"Int J Health Sci (Qassim)"},{"key":"R26-20250130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/jiaomr.jiaomr_108_21","article-title":"Colchicine as a therapeutic drug in the management of oral submucous fibrosis - A randomized clinical study","volume":"33","author":"M Mounika","year":"2021","journal-title":"J Indian Acad Oral Med Radiol"},{"key":"R27-20250130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0714.1995.tb01156.x","article-title":"Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing","volume":"24","author":"Murti","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"R29-20250130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/JPER.17-0359","article-title":"Effects of colchicine on gingival inflammation, apoptosis, and alveolar bone loss in experimental periodontitis","volume":"89","author":"Aral","year":"2018","journal-title":"J Periodontol"},{"key":"R30-20250130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5005\/jp-journals-10024-1806","article-title":"Effectiveness of aloe vera and antioxidant along with physiotherapy in the management of oral submucous fibrosis","volume":"17","author":"Singh","year":"2016","journal-title":"J Contemp Dent Pract"},{"key":"R31-20250130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/njms.NJMS_32_17","article-title":"Oral submucous fibrosis:Newer proposed classification with critical updates in pathogenesis and management strategies","volume":"8","author":"Passi","year":"2017","journal-title":"Natl J Maxillofac Surg"},{"key":"R32-20250130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jobcr.2020.09.004","article-title":"Efficacy of lycopene in management of oral submucous fibrosis\u2013A systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2020","journal-title":"J Oral Biol Craniofac Res"},{"key":"R33-20250130","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/odi.12715","article-title":"Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis:A meta-analysis","volume":"24","author":"Liu","year":"2018","journal-title":"Oral Dis"},{"key":"R34-20250130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/jcrt.JCRT_95_20","article-title":"Turmeric in the management of oral submucous fibrosis:A systematic review and meta-Analysis","volume":"17","author":"Rai","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R35-20250130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1051\/mbcb\/2021052","article-title":"Efficacy of spirulina in management of oral submucous fibrosis - A systematic review","volume":"28","author":"Kulkarni","year":"2022","journal-title":"J Oral Med Oral Surg"},{"key":"R36-20250130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jop.12789","article-title":"Aloe vera in treatment of oral submucous fibrosis:A systematic review and meta-analysis","volume":"48","author":"Al-Maweri","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"R37-20250130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0973-1482.136023","article-title":"Efficacy of oxitard capsules in the treatment of oral submucous fibrosis","volume":"11","author":"Patil","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R38-20250130","doi-asserted-by":"crossref","first-page":"e16339","DOI":"10.1097\/MD.0000000000016339","article-title":"Efficacy of salvia miltiorrhiza injection combined with steroids in the treatment of oral submucous fibrosis","volume":"98","author":"Xie","year":"2019","journal-title":"Med"},{"key":"R39-20250130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/ijdr.IJDR_929_20","article-title":"Efficacy of topical tulsi (ocimum sanctum) paste for the management of oral submucous fibrosis \u2013A clinical study","volume":"33","author":"Biswas","year":"2022","journal-title":"Indian J Dent Res"},{"key":"R40-20250130","first-page":"ZE01","article-title":"Hyperbaric oxygen therapy\u2014A novel treatment modality in oral submucous fibrosis:A review","volume":"9","author":"Ashwini Kumar","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R41-20250130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/JIHS.JIHS_20_20","article-title":"Nonsurgical treatment for oral submucous fibrosis:A comprehensive review","volume":"8","author":"Sandhu","year":"2020","journal-title":"J Integr Health Sci"},{"key":"R42-20250130","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/jpm12081272","article-title":"Comparative efficacy of interventions for the management of oral submucous fibrosis:A systematic review and network meta-analysis","volume":"12","author":"Gopinath","year":"2022","journal-title":"J Pers Med"},{"key":"R43-20250130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jobcr.2020.06.010","article-title":"Clinical efficacy of mouth exercising devices in oral submucous fibrosis:A systematic review","volume":"10","author":"Gondivkar","year":"2020","journal-title":"J Oral Biol Craniofac Res"},{"key":"R44-20250130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.sdentj.2020.11.005","article-title":"Laser as a promising non-invasive technique to treat oral submucous fibrosis:A systematic review of the literature","volume":"33","author":"Gupta","year":"2021","journal-title":"Saudi Dent J"},{"key":"R45-20250130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/kei140","article-title":"Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases:A possible new outlook through microarray analysis","volume":"45","author":"Ben-Chetrit","year":"2006","journal-title":"Rheumatology"},{"key":"R46-20250130","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin Ther"},{"key":"R47-20250130","first-page":"1365","article-title":"Recurrent aphthous stomatitis:Treatment with colchicine. An open trial of 54 cases","volume":"129","author":"Fontes","year":"2002","journal-title":"In Ann Dermatol Venereol"},{"key":"R48-20250130","first-page":"12","article-title":"Effectiveness of oral colchicine in the management of lichen planus","author":"Al-Sultany","year":"2020","journal-title":"Int J Pharm Res"},{"key":"R49-20250130","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jop.13020","article-title":"value of colchicine as treatment for recurrent oral ulcers:A systematic review","volume":"49","author":"Cabras","year":"2020","journal-title":"J Oral Pathol Med"},{"key":"R50-20250130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3892\/etm.2021.9712","article-title":"Colchicine in the treatment of refractory aphthous ulcerations:Review of the literature and two case reports","volume":"21","author":"Toader","year":"2021","journal-title":"Exp Ther Med"},{"key":"R51-20250130","first-page":"527","article-title":"Management of oral submucous fibrosis by two different drug regimens:A comparative study","volume":"10","author":"Krishnamoorthy","year":"2013","journal-title":"Dent Res J (Isfahan)"},{"key":"R52-20250130","first-page":"63","article-title":"A Comparison of different treatment modalities of management of OSMF","volume":"10","author":"Porwal","year":"2022","journal-title":"J Adv Med Dent Sci Res"},{"key":"R53-20250130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/njms.NJMS_5_17","article-title":"Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis","volume":"8","author":"Daga","year":"2017","journal-title":"Natl J Maxillofac Surg"},{"key":"R54-20250130","first-page":"41","article-title":"Effectiveness of oral colchicine with intralesional hyaluronidase and triamcinolone acetonide in patients with OSMF","volume":"9","author":"Khande","year":"2021","journal-title":"J Adv Med Dent Sci Res"},{"key":"R55-20250130","first-page":"8","article-title":"Evaluation of two different treatment modalities for the management of oral submucous fibrosis:A relative report and analysis","volume":"5","author":"Sheth","year":"2017","journal-title":"J Adv Med Dent Sci Res"},{"key":"R56-20250130","first-page":"79","article-title":"Comparison between efficacy of combined use of hyaluronidise and triamcinolone versus hyaluronidise, triamcinolone acetonide and oral colchicine in the treatment of oral submucous fibrosis","volume":"30","author":"Mostafa","year":"2021","journal-title":"Mymensingh Med J"},{"key":"R57-20250130","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1007\/s12070-023-03876-1","article-title":"Colchicine in the management of oral submucous fibrosis:A systematic review, meta-analysis, and GRADE-based assessment of certainty of evidence","volume":"75","author":"Rai","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1313_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:28:43Z","timestamp":1787837323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1313_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":56,"journal-issue":{"issue":"Suppl 5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_1313_24","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}